Phase II trial of induction chemotherapy with carboplatin and paclitaxel plus bevacizumab in patients with stage IIIA to IV nonsquamous non-small cell lung cancer.

Kazuhiro ImaiTaku NakagawaIkuo MatsuzakiKimito OrinoHajime SaitoKazuhiro SatoMasaaki SanoKatsutoshi NakayamaYusuke SatoSatoru MotoyamaKyoko NomuraHiroyuki ShibataYoshihiro Minamiya

Published in: Surgery today (2019)

Combined modality therapy with surgery after induction chemotherapy with CBDCA and PTX plus bevacizumab is clinically feasible and tolerable for patients with unknown or negative molecular profiles.

Keyphrases

locally advanced
metastatic colorectal cancer
minimally invasive
chemotherapy induced
coronary artery bypass
phase ii study
squamous cell carcinoma
stem cells
coronary artery disease
mesenchymal stem cells
study protocol